Reset
Showing 12 of 32 academic articles

A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma

Tan Zhang, Tan Zhang, Sina Zhang, Sina Zhang et al. • Frontiers in Cellular and Infection Microbiology (2021)

Cholangiocarcinoma (CCA) is a malignant hepatic tumor with a poor prognosis, which needs early diagnosis urgently. The gut microbiota has been shown to play a crucial role in the progression of liver cancer. Here, we explored a gut microbio...

DOAJ Open Access (DOAJ) DOI: 10.3389/fcimb.2021.751795

Robotic surgery

Michèle Diana, Jacques Marescaux • British journal of surgery (2015)

BACKGROUND: Proficiency in minimally invasive surgery requires intensive and continuous training, as it is technically challenging for unnatural visual and haptic perceptions. Robotic and computer sciences are producing innovations to augme...

OPENALEX DOI: https://doi.org/10.1002/bjs.9711

Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition

Susheel Kumar Nethi, Venugopal Gunda, Nagabhishek Sirpu Natesh, Brianna M. White et al. • iScience (2025)

Summary: Pancreatic cancer (PC) exhibits profound metabolic adaptations that support tumor progression, survival, and therapy resistance. Hypoxia-inducible factor-1α (HIF-1α) is a key regulator of these processes, promoting metabolic reprog...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.isci.2025.114088

Feasibility and effectiveness of automatic deep learning network and radiomics models for differentiating tumor stroma ratio in pancreatic ductal adenocarcinoma

Hongfan Liao, Jiang Yuan, Chunhua Liu, Jiao Zhang et al. • Insights into Imaging (2023)

Abstract Objective This study aims to compare the feasibility and effectiveness of automatic deep learning network and radiomics models in differentiating low tumor stroma ratio (TSR) from high TSR in pancreatic ductal adenocarcinoma (PDAC)...

DOAJ Open Access (DOAJ) DOI: 10.1186/s13244-023-01553-z

A Protein‐Centric Strategy Coupled with Match‐Between‐Run Glycoproteomics Enables Discovery of Robust Site‐Specific Glycan Biomarkers for Hepatocellular Carcinoma

Lei Liu, Taiheng Ma, Qi Liu, He Zhu et al. • Advanced Science (2026)

ABSTRACT Dysregulated protein glycosylation is a hallmark of cancer, and systematic investigation of glycosylation patterns is crucial for identifying biomarkers. However, current glycoproteomic studies are constrained by the limited quanti...

DOAJ Open Access (DOAJ) DOI: 10.1002/advs.202516299

Artificial intelligence in pancreatic cancer

Bowen Huang, Haoran Huang, Shuting Zhang, Dingyue Zhang et al. • Theranostics (2022)

Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%. The pancreatic cancer patients diagnosed with early screening have a median overall survival of nearly ten years, compared with 1.5 years for th...

OPENALEX cc-by DOI: https://doi.org/10.7150/thno.77949 PMC: 9576619

Risk of Ischemic Heart Disease in Patients With Postpancreatectomy Diabetes and Pancreatic Cancer: A Population‐Based Study

Daegwang Yoo, Minsun Kang, Jaehun Jung • Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (2023)

Background Postpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk fact...

DOAJ Open Access (DOAJ) DOI: 10.1161/JAHA.123.031321

Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types

Chiara Maria Lavinia Loeffler, Omar S. M. El Nahhas, Hannah Sophie Muti, Zunamys I. Carrero et al. • BMC Biology (2024)

Abstract Background Homologous recombination deficiency (HRD) is recognized as a pan-cancer predictive biomarker that potentially indicates who could benefit from treatment with PARP inhibitors (PARPi). Despite its clinical significance, HR...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12915-024-02022-9